Explore

Trendline Trendline
Researchers Propose New Obesity Drug Approach, Dropping GLP-1 Target

Researchers Propose New Obesity Drug Approach, Dropping GLP-1 Target

Researchers Propose New Obesity Drug Approach, Dropping GLP-1 Target
Trendline Trendline
Obesity and Diabetes Deals Surge in Q1 2026, Exceeding 2025 Total Value

Obesity and Diabetes Deals Surge in Q1 2026, Exceeding 2025 Total Value

Obesity and Diabetes Deals Surge in Q1 2026, Exceeding 2025 Total Value
Trendline Trendline
CMS Assigns Permanent Reimbursement J-Code for YARTEMLEA, Enhancing Access for TA-TMA Patients

CMS Assigns Permanent Reimbursement J-Code for YARTEMLEA, Enhancing Access for TA-TMA Patients

CMS Assigns Permanent Reimbursement J-Code for YARTEMLEA, Enhancing Access for TA-TMA Patients
Trendline Trendline
OpenAI Launches GPT-Rosalind for Advancements in Life Sciences

OpenAI Launches GPT-Rosalind for Advancements in Life Sciences

OpenAI Launches GPT-Rosalind for Advancements in Life Sciences
Trendline Trendline
ImmunityBio Faces Securities Fraud Lawsuit Amid FDA Warning

ImmunityBio Faces Securities Fraud Lawsuit Amid FDA Warning

ImmunityBio Faces Securities Fraud Lawsuit Amid FDA Warning
Trendline Trendline
Khondrion Begins Phase 3 Trial for Sonlicromanol in Mitochondrial Disease

Khondrion Begins Phase 3 Trial for Sonlicromanol in Mitochondrial Disease

Khondrion Begins Phase 3 Trial for Sonlicromanol in Mitochondrial Disease
Trendline Trendline
Vir Biotechnology and Astellas Finalize Collaboration for Prostate Cancer Treatment

Vir Biotechnology and Astellas Finalize Collaboration for Prostate Cancer Treatment

Vir Biotechnology and Astellas Finalize Collaboration for Prostate Cancer Treatment
Trendline Trendline
Alethio Therapeutics Unveils Antibody for Essential Thrombocythemia

Alethio Therapeutics Unveils Antibody for Essential Thrombocythemia

Alethio Therapeutics Unveils Antibody for Essential Thrombocythemia
Trendline Trendline
NorthStar Receives FDA Approval for Actinium-225 Drug Master File, Enhancing Radiopharmaceutical Development

NorthStar Receives FDA Approval for Actinium-225 Drug Master File, Enhancing Radiopharmaceutical Development

NorthStar Receives FDA Approval for Actinium-225 Drug Master File, Enhancing Radiopharmaceutical Development
Trendline Trendline
FDA Grants Fast Track Designation to Opna Bio's OPN-6602 for Multiple Myeloma Treatment

FDA Grants Fast Track Designation to Opna Bio's OPN-6602 for Multiple Myeloma Treatment

FDA Grants Fast Track Designation to Opna Bio's OPN-6602 for Multiple Myeloma Treatment
Trendline Trendline
GSK Receives Additional Marketing Approvals for Depemokimab in Europe and China

GSK Receives Additional Marketing Approvals for Depemokimab in Europe and China

GSK Receives Additional Marketing Approvals for Depemokimab in Europe and China
Trendline Trendline
Ardena Expands Bioanalytical Capabilities with New Laboratory in New Jersey

Ardena Expands Bioanalytical Capabilities with New Laboratory in New Jersey

Ardena Expands Bioanalytical Capabilities with New Laboratory in New Jersey